Vincerx Pharma Statistics

Total Valuation

Vincerx Pharma has a market cap or net worth of $1.44 million. The enterprise value is -$3.54 million.

Market Cap	1.44M
Enterprise Value	-3.54M

Important Dates

The next estimated earnings date is Tuesday, May 13, 2025, after market close.

Earnings Date	May 13, 2025
Ex-Dividend Date	n/a

Share Statistics

Vincerx Pharma has 5.23 million shares outstanding. The number of shares has increased by 78.22% in one year.

Current Share Class	5.23M
Shares Outstanding	5.23M
Shares Change (YoY)	+78.22%
Shares Change (QoQ)	+42.67%
Owned by Insiders (%)	5.61%
Owned by Institutions (%)	4.04%
Float	4.94M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.23
P/TBV Ratio	0.53
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.21

Current Ratio	1.21
Quick Ratio	1.14
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -431.29% and return on invested capital (ROIC) is -220.87%.

Return on Equity (ROE)	-431.29%
Return on Assets (ROA)	-138.54%
Return on Invested Capital (ROIC)	-220.87%
Return on Capital Employed (ROCE)	-1,066.92%
Revenue Per Employee	n/a
Profits Per Employee	-$2.31M
Employee Count	13
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -99.71% in the last 52 weeks. The beta is 1.39, so Vincerx Pharma's price volatility has been higher than the market average.

Beta (5Y)	1.39
52-Week Price Change	-99.71%
50-Day Moving Average	0.96
200-Day Moving Average	7.34
Relative Strength Index (RSI)	22.58
Average Volume (20 Days)	1,776,307

Short Selling Information

The latest short interest is 68,814, so 1.31% of the outstanding shares have been sold short.

Short Interest	68,814
Short Previous Month	191,883
Short % of Shares Out	1.31%
Short % of Float	1.39%
Short Ratio (days to cover)	0.19

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-29.06M
Pretax Income	-28.90M
Net Income	-30.07M
EBITDA	-29.01M
EBIT	-29.06M
Earnings Per Share (EPS)	-$15.85

Full Income Statement

Balance Sheet

The company has $4.99 million in cash and n/a in debt, giving a net cash position of $4.99 million or $0.95 per share.

Cash & Cash Equivalents	4.99M
Total Debt	n/a
Net Cash	4.99M
Net Cash Per Share	$0.95
Equity (Book Value)	2.72M
Book Value Per Share	1.22
Working Capital	1.13M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-26.13M
Capital Expenditures	n/a
Free Cash Flow	-26.13M
FCF Per Share	-$4.99

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Vincerx Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-78.22%
Shareholder Yield	n/a
Earnings Yield	-2,084.76%
FCF Yield	-1,811.15%

Analyst Forecast

The average price target for Vincerx Pharma is $40.00, which is 14,413.79% higher than the current price. The consensus rating is "Buy".

Price Target	$40.00
Price Target Difference	14,413.79%
Analyst Consensus	Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on January 28, 2025. It was a reverse split with a ratio of 0.05:1.

Last Split Date	Jan 28, 2025
Split Type	Reverse
Split Ratio	0.05:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1